BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010; 16(4): 418-424 [PMID: 20101765 DOI: 10.3748/wjg.v16.i4.418] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 110] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma XH, Wang S, Liu SY, Chen K, Wu ZY, Li DF, Mi YT, Hu LB, Chen ZW, Zhao XM. Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World J Gastroenterol 2019; 25(24): 3030-3043 [PMID: 31293339 DOI: 10.3748/wjg.v25.i24.3030] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Khattab M, Fouad M, Ahmed E. Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma. World J Hepatol 2015; 7(23): 2474-2481 [PMID: 26483869 DOI: 10.4254/wjh.v7.i23.2474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
3 Chen P, Li F. Diagnosis and treatment of hepatocellular carcinoma: A new beginning. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3719-3724 [DOI: 10.11569/wcjd.v20.i36.3719] [Reference Citation Analysis]
4 Hesketh RL, Zhu AX, Oklu R. Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma? Diagn Interv Radiol 2015;21:78-84. [PMID: 25430530 DOI: 10.5152/dir.2014.14237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
5 Lian H, Tang J, Sun YC, Zhang S. Mechanisms underlying vesicular stomatitis virus-induced apoptosis of HepG2 cells in vitroShijie Huaren Xiaohua Zazhi 2011; 19(7): 667-673 [DOI: 10.11569/wcjd.v19.i7.667] [Reference Citation Analysis]
6 Chen J, Qian Z, Li F, Li J, Lu Y. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma. Gut Liver 2017;11:112-20. [PMID: 27458175 DOI: 10.5009/gnl16063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ibrahim GH, Mahmoud MA, Aly NM. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients. Mol Biol Rep. 2013;40:7069-7075. [PMID: 24186850 DOI: 10.1007/s11033-013-2829-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
8 Alshati A, Bellapravalu S, Srinivasan I, Nadir A, Chuang KY. Imaging-Negative Hepatocellular Carcinoma Presents as an Intrabiliary Mass. ACG Case Rep J 2019;6:e00068. [PMID: 31616745 DOI: 10.14309/crj.0000000000000068] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kim H, Kim K, Yu SJ, Jang ES, Yu J, Cho G, Yoon JH, Kim Y. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring. PLoS One 2013;8:e63468. [PMID: 23717429 DOI: 10.1371/journal.pone.0063468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
10 Kong W, Xu H, Cheng J, Fang Z, Wang H, Zhang J, Wang X, Dai T, Gao Y. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study. Med Sci Monit 2020;26:e918824. [PMID: 31929496 DOI: 10.12659/MSM.918824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Laudien M, Häsler R, Wohlers J, Böck J, Lipinski S, Bremer L, Podschun R, Ambrosch P, Lamprecht P, Rosenstiel P, Till A. Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol 2011;4:564-73. [PMID: 21412229 DOI: 10.1038/mi.2011.9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
12 El-Far YM, Khodir AE, Noor AO, Almasri DM, Bagalagel AA, Diri RM, Kutbi HI, Al-Gayyar MMH. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro. Redox Rep 2020;25:17-25. [PMID: 32172678 DOI: 10.1080/13510002.2020.1739870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q, Shen G. Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells. Technol Cancer Res Treat 2016;15:487-97. [PMID: 26009496 DOI: 10.1177/1533034615587616] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
14 Liu CC, Yang H, Zhang R, Zhao JJ, Hao DJ. Tumour-associated antigens and their anti-cancer applications. Eur J Cancer Care (Engl). 2017;26. [PMID: 26853428 DOI: 10.1111/ecc.12446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
15 Ren WP, Yu MH, Xu P. Contrast-enhanced ultrasound vs contrast-enhanced computed tomography for diagnosis of small nodules (<3 cm) in the liver of patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2015; 23(7): 1149-1153 [DOI: 10.11569/wcjd.v23.i7.1149] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Yau WY, Shih HC, Tsai MH, Sheu JC, Chen CH, Chow LP. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma. J Proteomics. 2013;94:346-358. [PMID: 24125732 DOI: 10.1016/j.jprot.2013.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 2012;55:483-90. [PMID: 21953299 DOI: 10.1002/hep.24703] [Cited by in Crossref: 185] [Cited by in F6Publishing: 184] [Article Influence: 16.8] [Reference Citation Analysis]
18 Xie L, Li T, Hu F, Jiang Q, Wang Q, Gan N. A novel microfluidic chip and antibody-aptamer based multianalysis method for simultaneous determination of several tumor markers with polymerization nicking reactions for homogenous signal amplification. Microchemical Journal 2019;147:454-62. [DOI: 10.1016/j.microc.2019.03.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Maeda T, Kanzaki H, Chiba T, Ao J, Kanayama K, Maruta S, Kusakabe Y, Saito T, Kobayashi K, Kiyono S, Nakamura M, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Nakagawa R, Muroyama R, Kanda T, Maruyama H, Kato N. Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma. BMC Cancer. 2019;19:1088. [PMID: 31718608 DOI: 10.1186/s12885-019-6322-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
20 Abdel-Razik A, Elhelaly R, Elzehery R, El-Diasty A, Abed S, Elhammady D, Tawfik A. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study. Eur J Gastroenterol Hepatol 2016;28:599-605. [PMID: 26741637 DOI: 10.1097/MEG.0000000000000569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
21 Luo CL, Rong Y, Chen H, Zhang WW, Wu L, Wei D, Wei XQ, Mei LJ, Wang FB. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technol Cancer Res Treat 2019;18:1533033819846632. [PMID: 31106685 DOI: 10.1177/1533033819846632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
22 Li GJ, Chen QY, Harrison TJ, Wang XY, Hu LP, Yang QL, Li KW, Fang ZL. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Cancer Biomark 2017;18:241-8. [PMID: 28085009 DOI: 10.3233/CBM-160131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
23 Manga YB, Ko F, Yang Y, Hung J, Yang W, Huang H, Wu C. Ultra-fast and sensitive silicon nanobelt field-effect transistor for high-throughput screening of alpha-fetoprotein. Sensors and Actuators B: Chemical 2018;256:1114-21. [DOI: 10.1016/j.snb.2017.10.007] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Letters 2018;412:283-8. [DOI: 10.1016/j.canlet.2017.10.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 26.8] [Reference Citation Analysis]
25 Saad-Hussein A, Beshir S, Taha MM, Shahy EM, Shaheen W, Abdel-Shafy EA, Thabet E. Early prediction of liver carcinogenicity due to occupational exposure to pesticides. Mutat Res Genet Toxicol Environ Mutagen 2019;838:46-53. [PMID: 30678827 DOI: 10.1016/j.mrgentox.2018.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
26 Li P, Zhai Y, Liu H, Lv FD, Li N, Ding HG. Diagnostic value of serum AFP alone or in combination with glypican 3, VEGF or IGF-II for patients with primary hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(25): 2702-2706 [DOI: 10.11569/wcjd.v18.i25.2702] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
27 Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379:191-197. [PMID: 26213370 DOI: 10.1016/j.canlet.2015.07.018] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
28 Qi T, Liao J, Li Y, Peng J, Li W, Chu B, Li H, Wei Y, Qian Z. Label-free alpha fetoprotein immunosensor established by the facile synthesis of a palladium–graphene nanocomposite. Biosensors and Bioelectronics 2014;61:245-50. [DOI: 10.1016/j.bios.2014.05.021] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
29 Tampaki M, Doumba PP, Deutsch M, Koskinas J. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World J Hepatol 2015; 7(14): 1834-1842 [PMID: 26207165 DOI: 10.4254/wjh.v7.i14.1834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
30 Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. World J Gastroenterol 2012; 18(41): 5897-5904 [PMID: 23139605 DOI: 10.3748/wjg.v18.i41.5897] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
31 Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 2012;25:189-99. [PMID: 22988337 DOI: 10.1293/tox.25.189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
32 Xi L, Yang C. Evaluation of alpha-l-fucosidase for the diagnosis of hepatocellular carcinoma based on meta-analysis. Journal of Laboratory Medicine 2020;44:183-9. [DOI: 10.1515/labmed-2019-0152] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Liu XF, Hu ZD, Liu XC, Cao Y, Ding CM, Hu CJ. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Biochem. 2014;47:196-200. [PMID: 24362268 DOI: 10.1016/j.clinbiochem.2013.12.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
34 Mohamed AA, Omar AAA, El-Awady RR, Hassan SMA, Eitah WMS, Ahmed R, Khater A, Tantawi OMS, Mohamed AA. MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. J Transl Int Med 2020;8:32-40. [PMID: 32435610 DOI: 10.2478/jtim-2020-0006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Ping Z, Xu H, Liu T, Huang J, Meng Y, Xu X, Li W, Zhang L. Anti-hepatoma activity of the stiff branched β- d -glucan and effects of molecular weight. J Mater Chem B 2016;4:4565-73. [DOI: 10.1039/c6tb01299j] [Cited by in Crossref: 26] [Article Influence: 4.3] [Reference Citation Analysis]
36 Shiota G, Miura N. Biomarkers for hepatocellular carcinoma. Clin J Gastroenterol 2012;5:177-82. [PMID: 26182317 DOI: 10.1007/s12328-012-0301-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Liu H, Li P, Zhai Y, Qu CF, Zhang LJ, Tan YF, Li N, Ding HG. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 2010; 16(35): 4410-4415 [PMID: 20845507 DOI: 10.3748/wjg.v16.i35.4410] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
38 Chen M, Zheng T, Han S, Zhang L, Bai Y, Fang X, Ding SZ, Yang Y. A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients. Clin Res Hepatol Gastroenterol. 2015;39:215-221. [PMID: 25312778 DOI: 10.1016/j.clinre.2014.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Minamimoto R, Senda M, Terauchi T, Jinnouchi S, Inoue T, Iinuma T, Inoue T, Ito K, Iwata H, Uno K, Oku S, Oguchi K, Tsukamoto E, Nakashima R, Nishizawa S, Fukuda H, Murano T, Yoshida T. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey. Ann Nucl Med 2011;25:45-54. [PMID: 20953985 DOI: 10.1007/s12149-010-0428-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
40 Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, Li X, Zhou WC, Yi JF, Ren ZJ. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World J Gastroenterol 2010; 16(34): 4281-4290 [PMID: 20818811 DOI: 10.3748/wjg.v16.i34.4281] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
41 Kong W, Zuo X, Liang H, Hu J, Zhang H, Wang X, Chen W. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int. 2018;2018:1723184. [PMID: 30687735 DOI: 10.1155/2018/1723184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
42 Fu H, Yuan J, Zhou X, Sun Y, Huang Y, Hou L, Song C, Yang B, Zhen P, Gao R, Mao P, Lin L, Xu S, Xiao H, Wei K. Determination of Hepatocellular Carcinoma Serum Polypeptide Based on Antibody Pre-concentration Coupled with Mass Spectrometry. Chinese Journal of Analytical Chemistry 2012;40:1803-6. [DOI: 10.1016/s1872-2040(11)60590-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Nagai-Okatani C, Minamino N. Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure. PLoS One 2016;11:e0150210. [PMID: 27281159 DOI: 10.1371/journal.pone.0150210] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
44 Nagel T, Klaus F, Ibanez IG, Wege H, Lohse A, Meyer B. Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma-correlation with liver cancer and liver cirrhosis. Anal Bioanal Chem 2018;410:7965-77. [PMID: 30397756 DOI: 10.1007/s00216-018-1418-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Jin X, Zhang Y, Wang H, Zhang Y. Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection. IJGM 2022;Volume 15:1393-403. [DOI: 10.2147/ijgm.s344345] [Reference Citation Analysis]
46 Unić A, Derek L, Duvnjak M, Patrlj L, Rakić M, Kujundžić M, Renjić V, Štoković N, Dinjar P, Jukic A, Grgurević I. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. Ann Clin Biochem 2018;55:355-62. [DOI: 10.1177/0004563217726808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
47 Yu J, Wang YJ, Gao YT, Shi WX, Wang QH, Liu T, Xu YJ, Yang B, Du Z. Detection of HCC-associated gene expression by real-time fluorescence quantitative PCR to establish a molecular diagnostic index for HCC. Shijie Huaren Xiaohua Zazhi 2011; 19(6): 588-595 [DOI: 10.11569/wcjd.v19.i6.588] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Ibrahim HM, Elghannam MZ, Elkhawaga OAY, El-sokkary AM. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients. Saudi Journal of Biological Sciences 2021. [DOI: 10.1016/j.sjbs.2021.06.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Waidely E, Al-Yuobi AR, Bashammakh AS, El-Shahawi MS, Leblanc RM. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. Analyst. 2016;141:36-44. [PMID: 26606739 DOI: 10.1039/c5an01884f] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
50 Eisa NH, Ebrahim MA, Ragab M, Eissa LA, El-Gayar AM. Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. J Oncol Pharm Pract 2015;21:323-30. [PMID: 24769518 DOI: 10.1177/1078155214532698] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
51 Khalil A, Elgedawy J, Faramawi MF, Elfert A, Salama I, Abbass A, Elsaid H, Elsebaai H. Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions. Tumori 2013;99:100-7. [DOI: 10.1177/030089161309900117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
52 Fang P, Du L, Cai D. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) 2020;99:e19461. [PMID: 32195943 DOI: 10.1097/MD.0000000000019461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Ye G, Qin Y, Wang S, Pan D, Xu S, Wu C, Wang X, Wang J, Ye H, Shen H. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biol Ther 2019;20:711-9. [PMID: 30755064 DOI: 10.1080/15384047.2018.1564558] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
54 Zakhary NI, Khodeer SM, Shafik HE, Abdel Malak CA. Impact of PIVKA-II in diagnosis of hepatocellular carcinoma. J Adv Res. 2013;4:539-546. [PMID: 25685463 DOI: 10.1016/j.jare.2012.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
55 Li L, Shi W, Wang Z, Gong Q, Ma H. Sensitive Fluorescence Probe with Long Analytical Wavelengths for γ-Glutamyl Transpeptidase Detection in Human Serum and Living Cells. Anal Chem 2015;87:8353-9. [DOI: 10.1021/acs.analchem.5b01535] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
56 Benicky J, Sanda M, Pompach P, Wu J, Goldman R. Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease. Anal Chem 2014;86:10716-23. [PMID: 25302577 DOI: 10.1021/ac502727s] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
57 Wang T, Zhang KH. Progress in research of tumor markers for diagnosis of hepatocellular carcinoma in AFP-negative patients. Shijie Huaren Xiaohua Zazhi 2011; 19(33): 3420-3425 [DOI: 10.11569/wcjd.v19.i33.3420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Alyoussef A, Al-Gayyar MMH. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother 2018;103:362-72. [PMID: 29669302 DOI: 10.1016/j.biopha.2018.04.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
59 Eissa LA, Eisa NH, Ebrahim MA, Ragab M, El-Gayar AM. Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Sci Pharm 2013;81:763-75. [PMID: 24106672 DOI: 10.3797/scipharm.1307-09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
60 Li C, Li G, Miao R, Lu X, Zhong S, Sang X, Mao Y, Zhao H. Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. J Surg Oncol. 2012;105:687-691. [PMID: 21952992 DOI: 10.1002/jso.22103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
61 Rauchfuss F, Scheuerlein H, Götz M, Dittmar Y, Voigt R, Heise M, Settmacher U. [Hepatocellular carcinoma and cholangiocarcinoma]. Chirurg 2010;81:941-52; quiz 953. [PMID: 20827454 DOI: 10.1007/s00104-009-1864-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Zhao L, Mou DC, Peng JR, Huang L, Wu ZA, Leng XS. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients. World J Gastroenterol 2010; 16(32): 4072-4078 [PMID: 20731022 DOI: 10.3748/wjg.v16.i32.4072] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
63 Luke FE, Allen BC, Moshiri ST, Ho LM, Massey CM, Stinnett SS, Muir AJ, Jaffe TA. Multiphase Multi–Detector Row Computed Tomography in the Setting of Chronic Liver Disease and Orthotopic Liver Transplantation: Can a Series Be Eliminated in Order to Reduce Radiation Dose? Journal of Computer Assisted Tomography 2013;37:408-14. [DOI: 10.1097/rct.0b013e3182838680] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lee HJ, Cha HJ, Lim JS, Lee SH, Song SY, Kim H, Hancock WS, Yoo JS, Paik YK. Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients. J Proteome Res 2014;13:2328-38. [PMID: 24628331 DOI: 10.1021/pr4011519] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
65 Wen L, Li J, Guo H, Liu X, Zheng S, Zhang D, Zhu W, Qu J, Guo L, Du D, Jin X, Zhang Y, Gao Y, Shen J, Ge H, Tang F, Huang Y, Peng J. Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients. Cell Res 2015;25:1250-64. [PMID: 26516143 DOI: 10.1038/cr.2015.126] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
66 Han KQ, He XQ, Ma MY, Guo XD, Zhang XM, Chen J, Han H, Zhang WW, Zhu QG, Nian H, Ma LJ. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. World J Gastroenterol 2015; 21(16): 4864-4874 [PMID: 25944999 DOI: 10.3748/wjg.v21.i16.4864] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
67 Lu ZY, Cen C, Shao Z, Chen XH, Xu CF, Li YM. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study. World J Gastroenterol 2016; 22(5): 1884-1890 [PMID: 26855548 DOI: 10.3748/wjg.v22.i5.1884] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
68 Abd El Gawad IA, Mossallam GI, Radwan NH, Elzawahry HM, Elhifnawy NM. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. J Egypt Natl Canc Inst. 2014;26:79-85. [PMID: 24841158 DOI: 10.1016/j.jnci.2014.01.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
69 Tahon AM, El-ghanam MZ, Zaky S, Emran TM, Bersy AM, El-raey F, A.z. E, El Kharsawy AM, Johar D. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients. J Gastrointest Canc 2019;50:434-41. [DOI: 10.1007/s12029-018-0095-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
70 Hidaka M, Takatsuki M, Okudaira S, Soyama A, Muraoka I, Tanaka T, Yamaguchi I, Hara T, Miyaaki H, Ichikawa T, Hayashi T, Sakamoto I, Nakao K, Kuroki T, Kanematsu T, Eguchi S. The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver. Hepatol Int 2013;7:655-61. [DOI: 10.1007/s12072-012-9379-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
71 Hu B, Tian X, Sun J, Meng X. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Int J Mol Sci. 2013;14:23559-23580. [PMID: 24317431 DOI: 10.3390/ijms141223559] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
72 Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang J, Huang A, Tang H. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Arch Virol 2014;159:2397-410. [PMID: 24788845 DOI: 10.1007/s00705-014-2084-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
73 Jiang JW, Chen XM, Chen XH, Zheng SS. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol 2011; 17(31): 3605-3613 [PMID: 21987607 DOI: 10.3748/wjg.v17.i31.3605] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
74 Gan Y, Liang Q, Song X. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis. Tumour Biol. 2014;35:3953-3960. [PMID: 24395655 DOI: 10.1007/s13277-013-1563-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
75 Yang MY, Wu F, Fang F, Yang H, Zhang JF, Chen GD, Yang LY. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma. BMC Cancer 2021;21:772. [PMID: 34217251 DOI: 10.1186/s12885-021-08491-3] [Reference Citation Analysis]
76 Mu H, Lin KX, Zhao H, Xing S, Li C, Liu F, Lu HZ, Zhang Z, Sun YL, Yan XY, Cai JQ, Zhao XH. Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry. World J Gastroenterol 2014; 20(19): 5826-5838 [PMID: 24914343 DOI: 10.3748/wjg.v20.i19.5826] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
77 Omran D, Esmat S, Sedrac H, Elbadry A, Ismail D, Rashed L. Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?: . Egyptian Liver Journal 2011;1:43-6. [DOI: 10.1097/01.elx.0000397027.33294.16] [Reference Citation Analysis]
78 Yang H, Chen G, Fang F, Liu Z, Hiu Yan Lau S, Zhang J, Lau WY, Yang L. Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular Carcinoma. Int J Biol Markers 2013;28:286-97. [DOI: 10.5301/jbm.5000015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
79 Chen K, Zhang Z, Yu A, Li J, Liu J, Zhang X. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation. Biomed Res Int 2020;2020:6575724. [PMID: 33195697 DOI: 10.1155/2020/6575724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
80 Cheng XS, Sun SB, Zhong F, He K, Zhou J. Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma. Oncol Res 2016;24:239-45. [PMID: 27656834 DOI: 10.3727/096504016X14648701448011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
81 Matteucci C, Sorrentino R, Bellis L, Ettorre GM, Svicher V, Santoro R, Vennarecci G, Biasiolo A, Pontisso P, Scacciatelli D, Beneduce L, Sarrecchia C, Casalino P, Bernardini S, Pierimarchi P, Garaci E, Puoti C, Rasi G. Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol Res 2014;44:1008-18. [PMID: 24102797 DOI: 10.1111/hepr.12239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
82 Huang T, Chen QF, Chang BY, Shen LJ, Li W, Wu PH, Fan WJ. TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway. Dis Markers 2019;2019:7129214. [PMID: 31281549 DOI: 10.1155/2019/7129214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
83 Zhao F, Zhao J, Song L, Zhang Y, Guo Z, Yang K. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa. Apoptosis 2017;22:1461-72. [DOI: 10.1007/s10495-017-1421-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
84 Sakr MA, Mohamed KAH, Hussein AM, Fouad MH, Allam AS, Safwat E. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00090-y] [Reference Citation Analysis]
85 Zayed Mohamed N, Aly HF, Moneim El-Mezayen HA, El-Salamony HE. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicol Rep 2019;6:875-88. [PMID: 31516840 DOI: 10.1016/j.toxrep.2019.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
86 Su B, Luo P, Yang Z, Yu P, Li Z, Yin P, Zhou L, Fan J, Huang X, Lin X, Qiao Y, Xu G. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data. Anal Bioanal Chem 2019;411:6377-86. [DOI: 10.1007/s00216-019-02011-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Andres Ibarra R, Abbas R, Kombu RS, Zhang GF, Jacobs G, Lee Z, Brunengraber H, Sanabria JR. Disturbances in the glutathione/ophthalmate redox buffer system in the woodchuck model of hepatitis virus-induced hepatocellular carcinoma. HPB Surg 2011;2011:789323. [PMID: 21941408 DOI: 10.1155/2011/789323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
88 Meng XQ, Zhang W, Zhang F, Yin SY, Xie HY, Zhou L, Zheng SS. Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells. Oncol Lett 2016;11:2145-51. [PMID: 26998139 DOI: 10.3892/ol.2016.4167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
89 Luk JM, Liu AM. Proteomics of hepatocellular carcinoma in Chinese patients. OMICS 2011;15:261-6. [PMID: 21348761 DOI: 10.1089/omi.2010.0099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
90 Wang YL, Zhu ZJ, Teng DH, Yao Z, Gao W, Shen ZY. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation. World J Gastroenterol 2012; 18(19): 2408-2414 [PMID: 22654434 DOI: 10.3748/wjg.v18.i19.2408] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
91 Na K, Jeong SK, Lee MJ, Cho SY, Kim SA, Lee MJ, Song SY, Kim H, Kim KS, Lee HW. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients. Int J Cancer. 2013;133:408-415. [PMID: 23319432 DOI: 10.1002/ijc.28020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
92 Isaac A, Mohamed SM, Ahmed OA, Hassan AGM, Rasmy HS. Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment. Egypt J Intern Med 2021;33. [DOI: 10.1186/s43162-021-00078-5] [Reference Citation Analysis]
93 Kanzaki H, Chiba T, Ao J, Koroki K, Kanayama K, Maruta S, Maeda T, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Ogasawara S, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Yasui S, Tawada A, Arai M, Kanda T, Maruyama H, Mimura N, Kato J, Zen Y, Ohtsuka M, Iwama A, Kato N. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma. Sci Rep 2021;11:5303. [PMID: 33674622 DOI: 10.1038/s41598-021-84117-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Cheng N, Fu J, Chen D, Chen S, Wang H. An antibody-free liver cancer screening approach based on nanoplasmonics biosensing chips via spectrum-based deep learning. NanoImpact 2021;21:100296. [DOI: 10.1016/j.impact.2021.100296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Hesketh RL, Zhu AX, Oklu R. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care? Am J Clin Oncol 2015;38:431-6. [PMID: 25238287 DOI: 10.1097/COC.0000000000000123] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
96 Xing H, Qiu H, Ding X, Han J, Li Z, Wu H, Yan C, Li H, Han R, Zhang H, Li C, Wang M, Wu M, Shen F, Zheng Y, Yang T. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma. Biomark Med 2019;13:545-55. [PMID: 31140827 DOI: 10.2217/bmm-2018-0414] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
97 Zhang L, Zhao Y, Guan H, Zhang D. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis. Cancer Biomark 2022. [PMID: 35275521 DOI: 10.3233/CBM-210261] [Reference Citation Analysis]
98 Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294 [PMID: 28839428 DOI: 10.3748/wjg.v23.i29.5282] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 113] [Article Influence: 23.6] [Reference Citation Analysis]
99 Hsieh SY, He JR, Yu MC, Lee WC, Chen TC, Lo SJ, Bera R, Sung CM, Chiu CT. Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis. J Proteome Res 2011;10:4715-24. [PMID: 21877752 DOI: 10.1021/pr200519q] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
100 Ohgidani M, Komizu Y, Goto K, Ueoka R. Residual powders from Shochu distillation remnants induce apoptosis in human hepatoma cells via the caspase-independent pathway. J Biosci Bioeng 2012;114:104-9. [PMID: 22560085 DOI: 10.1016/j.jbiosc.2012.02.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
101 West MB, Hanigan MH. γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells. Arch Biochem Biophys 2010;504:177-81. [PMID: 20831856 DOI: 10.1016/j.abb.2010.08.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
102 Li L, Chen J, Chen X, Tang J, Guo H, Wang X, Qian J, Luo G, He F, Lu X, Ding Y, Yang Y, Huang W, Hou G, Lin X, Ouyang Q, Li H, Wang R, Jiang F, Pu R, Lu J, Jin M, Tan Y, Gonzalez FJ, Cao G, Wu M, Wen H, Wu T, Jin L, Chen L, Wang H. Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma. Cancer Lett. 2016;373:234-240. [PMID: 26850373 DOI: 10.1016/j.canlet.2016.01.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
103 Darweish MM, Abbas A, Ebrahim MA, Al-gayyar MMH. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. Journal of Pharmacy and Pharmacology 2014;66:1032-45. [DOI: 10.1111/jphp.12229] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
104 Hong Y, Long J, Li H, Chen S, Liu Q, Zhang B, He X, Wang Y, Li H, Li Y. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma. EBioMedicine. 2015;2:438-446. [PMID: 26137588 DOI: 10.1016/j.ebiom.2015.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
105 Mohamed FZ, Hussein YM, El-deen IM, Sabea MS. Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt. Mol Biol Rep 2014;41:1461-8. [DOI: 10.1007/s11033-013-2991-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
106 Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013;12:530-547. [PMID: 23400006 DOI: 10.1102/1470-7330.2012.0044] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
107 Liu C, Gong K, Mao X, Li W. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer. 2011;129:1519-1531. [PMID: 21128229 DOI: 10.1002/ijc.25817] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
108 Han J, Li J, Qian Y, Liu W, Liang J, Huang Z, Wang S, Zhao C. Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2019;43:585-93. [PMID: 30824368 DOI: 10.1016/j.clinre.2018.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
109 Yang S, Cai H, Hu B, Tu J. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Biosci Rep 2019;39:BSR20190615. [PMID: 31164410 DOI: 10.1042/BSR20190615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Sun T, Tang Y, Sun D, Bu Q, Li P. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis. Onco Targets Ther 2018;11:8925-35. [PMID: 30573979 DOI: 10.2147/OTT.S186230] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
111 Guo HM, Li JS, Zhang JP, Li DY, Li HF. Significance of serum sCD25 level in diagnosis of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(34): 5344-5349 [DOI: 10.11569/wcjd.v22.i34.5344] [Reference Citation Analysis]
112 Shao Y, Zhu B, Zheng R, Zhao X, Yin P, Lu X, Jiao B, Xu G, Yao Z. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery. J Proteome Res. 2015;14:906-916. [PMID: 25483141 DOI: 10.1021/pr500973d] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
113 Chen G, Ni S, Zhu S, Yang J, Yin Y. An electrochemical method to detect gamma glutamyl transpeptidase. Int J Mol Sci 2012;13:2801-9. [PMID: 22489126 DOI: 10.3390/ijms13032801] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
114 Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD. Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract 2012;18:335-42. [PMID: 21114800 DOI: 10.1111/j.1365-2753.2010.01599.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
115 Hussein TD. Serological tumor markers of hepatocellular carcinoma: a meta-analysis. Int J Biol Markers 2015;30:e32-42. [PMID: 25450646 DOI: 10.5301/jbm.5000119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
116 Zhang Z, Xu L, Wang Z. Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique. J Clin Lab Anal 2011;25:402-8. [PMID: 22086793 DOI: 10.1002/jcla.20491] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zhou XL, Mi YQ, Xu L, Liu YG, Zhong Y, Su ST. Clinical value of protein induced by vitamin K absence or antagonist-II in diagnosis of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(7): 425-433 [DOI: 10.11569/wcjd.v26.i7.425] [Reference Citation Analysis]
118 Wang X, Wang Q. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.Can J Gastroenterol Hepatol. 2018;2018:9049252. [PMID: 29805966 DOI: 10.1155/2018/9049252] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
119 Grepstad JO, Kaspar P, Solgaard O, Johansen IR, Sudbø AS. Photonic-crystal membranes for optical detection of single nano-particles, designed for biosensor application. Opt Express 2012;20:7954-65. [PMID: 22453468 DOI: 10.1364/OE.20.007954] [Cited by in Crossref: 45] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]